Schuster, W A <br/><br/>
Retinoic acid potentiates phorbol ester-mediated induction of urokinase and plasminogen activator inhibitor type 2 in human myeloid leukemic cell lines.  [electronic resource] 

 -  Endocrinology  Oct 1993 
 - 1724-30 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0013-7227 
<br/><br/><label>Standard No.: </label>10.1210/endo.133.4.8404615  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Drug Synergism<br/>Enzyme Induction<br/>Humans<br/>Leukemia, Myeloid--metabolism<br/>Plasminogen Activator Inhibitor 2--genetics<br/>Plasminogen Activators--metabolism<br/>RNA, Messenger--metabolism<br/>Receptors, Cell Surface--drug effects<br/>Receptors, Urokinase Plasminogen Activator<br/>Templates, Genetic<br/>Tetradecanoylphorbol Acetate--pharmacology<br/>Tretinoin--pharmacology<br/>Tumor Cells, Cultured<br/>Urokinase-Type Plasminogen Activator--genetics